Connect Biopharma Holdings LCNTB
13F holders, Q3 2025 (September 30)15holders
1famous investor
$1.51avg. 13F price*
At the end of Q3 2025, 15 institutions reported holding Connect Biopharma Holdings L (CNTB) in their 13F filings. The largest holders were BML Capital Management, LLC ($1.9M), Renaissance Technologies ($239K) and Marshall Wace, LLP ($86K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Holdings L
- CUSIP
- G23549101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $144K |
| Exits | 0 | $0 |
Ownership 15 holders
| BML Capital Management, LLC | 1.76% | Reduce -30.4% | 1,267,500 | $1.9M |
| Renaissance Technologies | 0.00% | Add +10.1% | 158,200 | $239K |
| Marshall Wace, LLP | 0.00% | New | 58,031 | $86K |
| Koa Wealth Management, LLC | 0.06% | No change | 49,600 | $75K |
| XTX Topco Ltd | 0.00% | Reduce -17.8% | 23,724 | $35K |
| Geode Capital Management, LLC | 0.00% | No change | 23,320 | $35K |
| Susquehanna International Group, LLP | 0.00% | New | 13,748 | $20K |
| Monograph Wealth Advisors, LLC | 0.00% | New | 11,130 | $17K |
| HRT Financial LP | 0.00% | New | 10,457 | $15K |
| Citigroup Inc. | 0.00% | New | 4,214 | $6K |
| Rhumbline Advisers | 0.00% | Reduce -67.1% | 780 | $1K |
| UBS Group AG | 0.00% | Add +378.6% | 201 | $304 |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $179 |
| Morgan Stanley | 0.00% | No change | 100 | $151 |
| SBI Securities Co., Ltd. | 0.00% | Add +16.7% | 7 | $11 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Holdings L the manager owns.